Anti-Diabetes Drug Lowers the Risk of Heart Failure
Canagliflozin is an anti-diabetes drug belongs to the gliflozin class or sodium-glucose transport subtype two inhibitors. Canagliflozin is administered either as a monotherapy or with metformin, sulfonylurea drugs, pioglitazone or insulin to achieve adequate glycemic control while treating diabetes patients.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer